These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 22890172
1. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents. Hu Y, Xia Q, Shangguan S, Liu X, Hu Y, Sheng R. Molecules; 2012 Aug 13; 17(8):9683-96. PubMed ID: 22890172 [Abstract] [Full Text] [Related]
2. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency. Buravchenko GI, Scherbakov AM, Dezhenkova LG, Bykov EE, Solovieva SE, Korlukov AA, Sorokin DV, Monzote Fidalgo L, Shchekotikhin AE. Bioorg Chem; 2020 Nov 13; 104():104324. PubMed ID: 33142432 [Abstract] [Full Text] [Related]
3. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides. Amin KM, Ismail MM, Noaman E, Soliman DH, Ammar YA. Bioorg Med Chem; 2006 Oct 15; 14(20):6917-23. PubMed ID: 16843668 [Abstract] [Full Text] [Related]
8. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives. Zarranz B, Jaso A, Aldana I, Monge A. Bioorg Med Chem; 2004 Jul 01; 12(13):3711-21. PubMed ID: 15186857 [Abstract] [Full Text] [Related]
9. Novel Quinoxaline-2-Carbonitrile-1,4-Dioxide Derivatives Suppress HIF1α Activity and Circumvent MDR in Cancer Cells. Scherbakov AM, Borunov AM, Buravchenko GI, Andreeva OE, Kudryavtsev IA, Dezhenkova LG, Shchekotikhin AE. Cancer Invest; 2018 Mar 16; 36(3):199-209. PubMed ID: 29624460 [Abstract] [Full Text] [Related]
12. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides. Monge A, Palop JA, López de Ceráin A, Senador V, Martínez-Crespo FJ, Sainz Y, Narro S, García E, de Miguel C, González M. J Med Chem; 1995 May 12; 38(10):1786-92. PubMed ID: 7752202 [Abstract] [Full Text] [Related]
13. Synthesis, hypoxia-selective cytotoxicity of new 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives. Xia Q, Zhang L, Zhang J, Sheng R, Yang B, He Q, Hu Y. Eur J Med Chem; 2011 Mar 12; 46(3):919-26. PubMed ID: 21281992 [Abstract] [Full Text] [Related]
14. Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity. Buravchenko GI, Scherbakov AM, Korlukov AА, Dorovatovskii PV, Shchekotikhin AE. Curr Org Synth; 2020 Mar 12; 17(1):29-39. PubMed ID: 32103715 [Abstract] [Full Text] [Related]
19. Design, combinatorial synthesis and biological evaluations of novel 3-amino-1'-((1-aryl-1H-1,2,3-triazol-5-yl)methyl)-2'-oxospiro[benzo[a] pyrano[2,3-c]phenazine-1,3'-indoline]-2-carbonitrile antitumor hybrid molecules. Lu Y, Wang L, Wang X, Xi T, Liao J, Wang Z, Jiang F. Eur J Med Chem; 2017 Jul 28; 135():125-141. PubMed ID: 28441581 [Abstract] [Full Text] [Related]